We are live on ! Find out more
HOOK icon

HOOKIPA Pharma

Delisted

HOOK was delisted on the 7th of August, 2025.

44 hedge funds and large institutions have $25.7M invested in HOOKIPA Pharma in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9.36% less ownership

Funds ownership: 60.53% → 51.17% (-9.4%)

17% less funds holding

Funds holding: 53 → 44 (-9)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

52% less capital inflows, than outflows

Capital inflows: $3.07M | Capital outflows: $6.38M

62% less call options, than puts

Call options by funds: $10K | Put options by funds: $26K

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

Holders
44
Holders Change
-9
Holders Change %
-16.98%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
9
Reduced
15
Closed
12
Calls
$10​K
Puts
$26​K
Net Calls
-⁠$16​K
Net Calls Change
+$12​K

HOOK Hedge Fund Activity: Q3 2023 in Review

44 of the 6,315 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2023, worth a combined $25.7M — down 36% from $40.1M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of HOOK and 3 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 9 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.67M. The largest seller was Redmile Group, cutting an estimated $1.63M.

  • 44 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2023, down from 53 in Q2 2023.
  • Funds reported $25.7M of HOOKIPA Pharma stock for Q3 2023, down 36% quarter-over-quarter.
  • 3 funds opened new HOOKIPA Pharma positions in Q3 2023 and 12 closed out, a net change of -9 holders.
  • The largest HOOKIPA Pharma buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.67M added.
  • The largest HOOKIPA Pharma seller in Q3 2023 was Redmile Group, an estimated $1.63M sold.

Based on aggregated 13F filings for Q3 2023.